Target intelligence / Profile preview

Ribosomal protein S12 pseudogene 23 (None)

Target
None
Molecular classification
pseudogene, noncoding RNA segment
01

Overview

Ribosomal protein S12 pseudogene 23 is a processed pseudogene derived from the coding gene for ribosomal protein S12, a component of the small (40S) ribosomal subunit. Pseudogenes are noncoding DNA segments that resemble functional genes but generally do not produce active proteins. While the parental RPS12 gene encodes a ribosomal protein vital for ribosome assembly and protein synthesis[5][6], the pseudogene variant 23 does not have protein-coding or documented biological function. In the broader context, some pseudogenes may contribute to regulatory functions in RNA biology, but there is currently no specific evidence of biological function or disease association for ribosomal protein S12 pseudogene 23[7]. It is not recognized as a therapeutic or diagnostic target, nor does it interact with existing drugs. The "ribosomal protein S12 pseudogene 23" entry is a genomic artifact documented for completeness in databases but does not encode a protein or serve as a molecule for drug interaction or disease targeting[1][4]. The name is correct, but it refers to a non-functional pseudogene, not a canonical receptor, enzyme, or protein. If you are seeking molecular targets relevant for therapeutic intervention, you should refer to the parent coding gene: Ribosomal protein S12 (RPS12), a structural constituent of ribosomes involved in translation[5][6].

Other names
RPS12P23similar database symbols
02

Mechanism of action

None

03

Biological functions

None
04

Disease associations

None direct

Beyond the preview

Go deeper on Ribosomal protein S12 pseudogene 23 (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S12 pseudogene 23 (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call